Lipid or immunohistochemical stains may be necessary to differentiate between squamous intraepithelial neoplasia and intraepithelial spread of sebaceous gland carcinoma. Treatment. The treatment ...

Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer, among which 82% arise from actinic keratosis (AK) characterized by lesions of epidermal keratinocyte ...

The pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast period. Increasing awareness about ...

OSSN encompasses a spectrum of epithelial squamous malignancies ranging from corneal and/or conjunctival intraepithelial neoplasia to invasive SCC. It is the most common non-pigmented ocular surface ...

She also developed low-grade squamous intraepithelial lesions of the cervix that were attributed to HPV infection. The cervical dysplasia required localized surgical resection. Due to poor response of ...

8 Previous reports have questioned the utility of histological grading of oesophageal squamous intraepithelial neoplasia (IEN ... Documenting these precursor lesions of OSCC should assist in the ...

DARE-HPV is a proposed treatment for HPV-related cervical ... high-grade cervical lesions (also called high-grade squamous intraepithelial lesions (HSIL) or high-grade cervical intraepithelial ...

Cervical cancer is usually caused by HPV infection. Exposure to multiple sexual partners, especially without using a condom, increases the risk of HPV. In utero diethylstilbestrol (DES) exposure ...

and outcomes of surgical treatment of eyelid squamous cell carcinoma (SCC). Methods: A retrospective review of all eyelid SCCs treated between 1992 and 2001. Results: 51 cases were identified in 50 ...

Determinants of induced abortion among women of reproductive age: evidence from the 2013 and 2019 Sierra Leone Demographic and Health Survey.

Most existing treatments can slow the progression of Alzheimer’s symptoms by six months to a year, but they don’t stop the disease. Now, a new class of medications is offering hope and buying more ...